Hanmi Pharmaceutical (KRX:128940) has an average rating of buy and mean price target of 658,666.70 won, according to analysts polled by FactSet.
What else is happening in Research?
Research
Macquarie Initiates Pursuit Attractions and Hospitality With Outperform Rating, $62 Price Target
Pursuit Attractions and Hospitality (PRSU) has an average rating of buy and mean price target of $61.80, according to analysts polled by FactSet.Price: $48.66, Change: $+0.11, Percent Change: +0.23%
$PRSU
Research
UBS Downgrades First Citizens BancShares to Neutral From Buy, Adjusts PT to $2,250 From $2,325
First Citizens BancShares (FCNCA) has an average rating of hold and mean price target of $2,324.08, according to analysts polled by FactSet.Price: $2175.51, Change: $+2.51, Percent Change: +0.12%
$FCNCA
Research
Arqaam Capital Reduces Catrion Catering's PT, Affirms Buy Rating
Arqaam Capital on Monday lowered the price target for airlines-focused catering company Catrion Catering (SASE:6004) to 90.00 Saudi riyals from 112.00 riyals and kept its rating at buy.
SASE:6004